scholarly article | Q13442814 |
P356 | DOI | 10.1136/JNNP-2012-302674 |
P698 | PubMed publication ID | 23085933 |
P50 | author | Catherine Lynch | Q58028141 |
Susan Byrne | Q61827445 | ||
Arun L W Bokde | Q78619693 | ||
Peter Bede | Q87738140 | ||
Marwa Elamin | Q114339892 | ||
Norah Jordan | Q114339900 | ||
Orla Hardiman | Q30423350 | ||
Russell McLaughlin | Q37829009 | ||
Harald Hampel | Q38328382 | ||
Andrew J. Fagan | Q42553744 | ||
Niall P. Pender | Q43564435 | ||
P2093 | author name string | Laura Gallagher | |
P2860 | cites work | The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). | Q53535985 |
Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. | Q55041563 | ||
Amyotrophic lateral sclerosis | Q55877676 | ||
Sensorimotor Functional Connectivity Changes in Amyotrophic Lateral Sclerosis | Q57911767 | ||
Excellent inter‐rater, intra‐rater, and telephone‐administered reliability of the ALSFRS‐R in a multicenter clinical trial | Q58287999 | ||
Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS | Q24633692 | ||
A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD | Q24634583 | ||
Voxel-based morphometry–the methods | Q28138780 | ||
Nonparametric permutation tests for functional neuroimaging: a primer with examples | Q28211607 | ||
SOMATIC MOTOR AND SENSORY REPRESENTATION IN THE CEREBRAL CORTEX OF MAN AS STUDIED BY ELECTRICAL STIMULATION | Q29029673 | ||
Advances in functional and structural MR image analysis and implementation as FSL | Q29547164 | ||
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest | Q29615076 | ||
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis | Q29619074 | ||
Establishing subtypes of the continuum of frontal lobe impairment in amyotrophic lateral sclerosis | Q31105297 | ||
Widespread sensorimotor and frontal cortical atrophy in Amyotrophic Lateral Sclerosis | Q33241059 | ||
Motor network degeneration in amyotrophic lateral sclerosis: a structural and functional connectivity study | Q33741815 | ||
Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis | Q34281282 | ||
Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family | Q34472281 | ||
Differential corticospinal tract degeneration in homozygous 'D90A' SOD-1 ALS and sporadic ALS. | Q35098534 | ||
Pattern of spread and prognosis in lower limb-onset ALS. | Q35239043 | ||
Presymptomatic spinal cord neurometabolic findings in SOD1-positive people at risk for familial ALS. | Q35240090 | ||
Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72 | Q35752001 | ||
Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study | Q35859698 | ||
Diffusion tensor imaging and voxel based morphometry study in amyotrophic lateral sclerosis: relationships with motor disability | Q36227112 | ||
Impaired action knowledge in amyotrophic lateral sclerosis | Q37179006 | ||
ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration | Q37593829 | ||
Neurodevelopmental and neurodegenerative diseases - is there a pathophysiological link? Attention-deficit/hyperactivity disorder and amyotrophic lateral sclerosis as examples | Q40140962 | ||
Global brain atrophy and corticospinal tract alterations in ALS, as investigated by voxel-based morphometry of 3-D MRI. | Q40368684 | ||
Detection of motor cortex thinning and corticospinal tract involvement by quantitative MRI in amyotrophic lateral sclerosis | Q43511549 | ||
Volumetric analysis reveals corticospinal tract degeneration and extramotor involvement in ALS. | Q43797795 | ||
The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study | Q44591084 | ||
Structural MRI reveals cortical thinning in amyotrophic lateral sclerosis | Q45341661 | ||
Upper and extra-motoneuron involvement in early motoneuron disease: a diffusion tensor imaging study | Q46092568 | ||
A voxel-based morphometry study of patterns of brain atrophy in ALS and ALS/FTLD. | Q46242205 | ||
Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: studies with [11C]flumazenil PET. | Q46447991 | ||
The diagnostic pathway and prognosis in bulbar-onset amyotrophic lateral sclerosis | Q48207344 | ||
Voxel-based morphometry study of brain volumetry and diffusivity in amyotrophic lateral sclerosis patients with mild disability. | Q48235979 | ||
Cognitive functions and white matter tract damage in amyotrophic lateral sclerosis: a diffusion tensor tractography study | Q48827615 | ||
Frontal lobe dysfunction in amyotrophic lateral sclerosis. A PET study | Q48839997 | ||
Frontotemporal white matter changes in amyotrophic lateral sclerosis | Q48987798 | ||
Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. | Q51014067 | ||
Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. | Q51103719 | ||
Progression in ALS is not linear but is curvilinear. | Q51691332 | ||
Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. | Q51868850 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | amyotrophic lateral sclerosis | Q206901 |
neuroimaging | Q551875 | ||
P304 | page(s) | 766-773 | |
P577 | publication date | 2012-10-20 | |
P1433 | published in | Journal of Neurology, Neurosurgery and Psychiatry | Q1599804 |
P1476 | title | Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality | |
P478 | volume | 84 |
Q38793324 | A Cross-sectional population-based investigation into behavioral change in amyotrophic lateral sclerosis: subphenotypes, staging, cognitive predictors, and survival |
Q48146205 | ALFF Value in Right Parahippocampal Gyrus Acts as a Potential Marker Monitoring Amyotrophic Lateral Sclerosis Progression: a Neuropsychological, Voxel-Based Morphometry, and Resting-State Functional MRI Study |
Q36479616 | ALS biomarkers for therapy development: State of the field and future directions |
Q90675194 | Abnormal Functional Connectivity Density in Amyotrophic Lateral Sclerosis |
Q90351947 | Abnormal topological organization of structural covariance networks in amyotrophic lateral sclerosis |
Q48765852 | Additional resources and the default mode network: Evidence of increased connectivity and decreased white matter integrity in amyotrophic lateral sclerosis |
Q92378722 | Applying the D50 disease progression model to gray and white matter pathology in amyotrophic lateral sclerosis |
Q39413097 | Biomarkers in Neurodegenerative Diseases |
Q64228443 | Clinical Measures of Bulbar Dysfunction in ALS |
Q59813023 | Clinical and Radiological Markers of Extra-Motor Deficits in Amyotrophic Lateral Sclerosis |
Q36045826 | Controversies and priorities in amyotrophic lateral sclerosis |
Q48605539 | Cortical thickness in ALS: towards a marker for upper motor neuron involvement |
Q35053698 | Cortical thinning and clinical heterogeneity in amyotrophic lateral sclerosis |
Q58111007 | Corticospinal tract degeneration in ALS unmasked in T1-weighted images using texture analysis |
Q36209956 | Development of an Automated MRI-Based Diagnostic Protocol for Amyotrophic Lateral Sclerosis Using Disease-Specific Pathognomonic Features: A Quantitative Disease-State Classification Study |
Q55127801 | Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: A post mortem whole brain sampling strategy for the integration of ultra-high-field MRI and quantitative neuropathology. |
Q92537437 | Editorial: Biomarkers and Clinical Indicators in Motor Neuron Disease |
Q35221959 | Exposing asymmetric gray matter vulnerability in amyotrophic lateral sclerosis. |
Q89564264 | Extrapyramidal deficits in ALS: a combined biomechanical and neuroimaging study |
Q44215931 | Focal thinning of the motor cortex mirrors clinical features of amyotrophic lateral sclerosis and their phenotypes: a neuroimaging study |
Q40556132 | Glial activation colocalizes with structural abnormalities in amyotrophic lateral sclerosis. |
Q52098090 | Gray matter and white matter changes in non-demented amyotrophic lateral sclerosis patients with or without cognitive impairment: A combined voxel-based morphometry and tract-based spatial statistics whole-brain analysis. |
Q33564750 | Groupwise multi-atlas segmentation of the spinal cord's internal structure |
Q40198465 | High-Resolution 7T MR Imaging of the Motor Cortex in Amyotrophic Lateral Sclerosis |
Q26860864 | Lessons of ALS imaging: Pitfalls and future directions - A critical review |
Q47352723 | Longitudinal structural changes in ALS: a three time-point imaging study of white and gray matter degeneration |
Q47844673 | MR Imaging-based Estimation of Upper Motor Neuron Density in Patients with Amyotrophic Lateral Sclerosis: A Feasibility Study |
Q92388747 | MRI cortical feature of bulbar impairment in patients with amyotrophic lateral sclerosis |
Q48239799 | MRI in amyotrophic lateral sclerosis: more than a promise |
Q64087673 | Machine Learning in Amyotrophic Lateral Sclerosis: Achievements, Pitfalls, and Future Directions |
Q33863021 | Memory deficits in amyotrophic lateral sclerosis are not exclusively caused by executive dysfunction: a comparative neuropsychological study of amnestic mild cognitive impairment |
Q35202637 | Microstructural changes across different clinical milestones of disease in amyotrophic lateral sclerosis |
Q34682155 | Microstructural white matter changes underlying cognitive and behavioural impairment in ALS--an in vivo study using DTI |
Q48103956 | Morphometric correlates of dysarthric deficit in amyotrophic lateral sclerosis |
Q45869420 | Motoneuron Disease: Clinical |
Q37170150 | Multiparametric MRI study of ALS stratified for the C9orf72 genotype |
Q38384260 | Neuroimaging as a New Diagnostic Modality in Amyotrophic Lateral Sclerosis |
Q30873214 | Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changes |
Q52093140 | Neuroimaging patterns along the ALS-FTD spectrum: a multiparametric imaging study. |
Q40094411 | Occipital cortical gyrification reductions associate with decreased functional connectivity in amyotrophic lateral sclerosis |
Q64065356 | Pathological Crying and Laughing in Motor Neuron Disease: Pathobiology, Screening, Intervention |
Q92202377 | Patterned functional network disruption in amyotrophic lateral sclerosis |
Q90294083 | Precentral degeneration and cerebellar compensation in amyotrophic lateral sclerosis: A multimodal MRI analysis |
Q50091767 | Quantitative susceptibility mapping of the motor cortex: a comparison of susceptibility among patients with amyotrophic lateral sclerosis, cerebrovascular disease, and healthy controls |
Q87147138 | Regional alterations in cortical thickness and white matter integrity in amyotrophic lateral sclerosis |
Q91936690 | Retinal correlates of neurological disorders |
Q58125489 | Revisiting the pathoanatomy of pseudobulbar affect: mechanisms beyond corticobulbar dysfunction |
Q48331848 | Semiautomated Evaluation of the Primary Motor Cortex in Patients with Amyotrophic Lateral Sclerosis at 3T. |
Q45911042 | Sexual dimorphism in ALS: exploring gender-specific neuroimaging signatures. |
Q33908623 | Side of limb-onset predicts laterality of gray matter loss in amyotrophic lateral sclerosis. |
Q64119028 | Spinal Cord Imaging in Amyotrophic Lateral Sclerosis: Historical Concepts-Novel Techniques |
Q41581020 | Subtle retinal pathology in amyotrophic lateral sclerosis |
Q33568729 | Survival prediction in Amyotrophic lateral sclerosis based on MRI measures and clinical characteristics |
Q60634009 | The Clinical and Radiological Spectrum of Hippocampal Pathology in Amyotrophic Lateral Sclerosis |
Q48721254 | The segmental diffusivity profile of amyotrophic lateral sclerosis associated white matter degeneration |
Q58125306 | The selective anatomical vulnerability of ALS: ‘disease-defining’ and ‘disease-defying’ brain regions |
Q64075393 | Tracking a Fast-Moving Disease: Longitudinal Markers, Monitoring, and Clinical Trial Endpoints in ALS |
Q33822826 | Virtual brain biopsies in amyotrophic lateral sclerosis: Diagnostic classification based on in vivo pathological patterns |
Q38883070 | Voxel-Wise Meta-Analysis of Gray Matter Changes in Amyotrophic Lateral Sclerosis |
Q34061536 | Voxel-based MRI intensitometry reveals extent of cerebral white matter pathology in amyotrophic lateral sclerosis |
Q27007017 | What does imaging reveal about the pathology of amyotrophic lateral sclerosis? |
Q34044019 | Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis |
Q39032298 | Widespread temporo-occipital lobe dysfunction in amyotrophic lateral sclerosis |
Q48600153 | miR-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients. |